Zobrazeno 1 - 10
of 159
pro vyhledávání: '"Masaki Fukui"'
Publikováno v:
Case Reports in Ophthalmology, Vol 14, Iss 1, Pp 673-678 (2023)
Introduction: With the increasing use of immune checkpoint inhibitors, ocular adverse events have gained attention. We describe a case of atypical keratitis presumably induced by atezolizumab, a programmed cell death ligand 1 inhibitor. Case Presenta
Externí odkaz:
https://doaj.org/article/2f93f037dd7949ae82c4f3e4b8a98cda
Publikováno v:
Cornea: The Journal of Cornea & External Disease; Jun2024, Vol. 43 Issue 6, p740-745, 6p
Autor:
Ken Nagino, Yuichi Okumura, Masahiro Yamaguchi, Jaemyoung Sung, Masashi Nagao, Kenta Fujio, Yasutsugu Akasaki, Tianxiang Huang, Kunihiko Hirosawa, Masao Iwagami, Akie Midorikawa-Inomata, Keiichi Fujimoto, Atsuko Eguchi, Yukinobu Okajima, Koji Kakisu, Yuto Tei, Takefumi Yamaguchi, Daisuke Tomida, Masaki Fukui, Yukari Yagi-Yaguchi, Yuichi Hori, Jun Shimazaki, Shuko Nojiri, Yuki Morooka, Alan Yee, Maria Miura, Mizu Ohno, Takenori Inomata
Publikováno v:
JMIR Research Protocols, Vol 12, p e45218 (2023)
BackgroundDry eye disease (DED) is one of the most common ocular surface diseases. Numerous patients with DED remain undiagnosed and inadequately treated, experiencing various subjective symptoms and a decrease in quality of life and work productivit
Externí odkaz:
https://doaj.org/article/b27924c66e484652b646b16b6d87587d
Autor:
Masaki, Fukui
Publikováno v:
KGPS review : Kwansei Gakuin policy studies review. 30:73-91
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::a2994518407d32cf8b8e184f11a64523
http://hdl.handle.net/10236/00030712
http://hdl.handle.net/10236/00030712
Publikováno v:
PLoS ONE, Vol 15, Iss 5, p e0233381 (2020)
It has been suggested that functional visual acuity (VA) testing may be able to measure both the visual performance and cognitive ability needed for driving and help to reduce the number of road traffic accidents. The aim of this study was to investi
Externí odkaz:
https://doaj.org/article/cc40e2659f2e4f889772ed62c0652625
Autor:
Yuma Ito, Masaki Fukui, Mamoru Kanda, Ko Morishita, Yoshimichi Shoji, Tatsuya Kitao, Eiichi Hinoi, Hiroaki Shirahase
Publikováno v:
Journal of Pharmacological Sciences, Vol 137, Iss 1, Pp 38-46 (2018)
The anti-diabetic and anti-obesity effects of the allosteric protein tyrosine phosphatase 1B (PTP1B) inhibitor 4-(biphenyl-4-ylmethylsulfanylmethyl)-N-(hexane-1-sulfonyl)benzoylamide (KY-226) were pharmacologically evaluated. KY-226 inhibited human P
Externí odkaz:
https://doaj.org/article/27923f6ad7b74318827ed6a19e8b5570
Autor:
Ken Nagino, Yuichi Okumura, Masahiro Yamaguchi, Jaemyoung Sung, Masashi Nagao, Kenta Fujio, Yasutsugu Akasaki, Tianxiang Huang, Kunihiko Hirosawa, Masao Iwagami, Akie Midorikawa-Inomata, Keiichi Fujimoto, Atsuko Eguchi, Yukinobu Okajima, Koji Kakisu, Yuto Tei, Takefumi Yamaguchi, Daisuke Tomida, Masaki Fukui, Yukari Yagi-Yaguchi, Yuichi Hori, Jun Shimazaki, Shuko Nojiri, Yuki Morooka, Alan Yee, Maria Miura, Mizu Ohno, Takenori Inomata
BACKGROUND Dry eye disease (DED) is one of the most common ocular surface diseases. Numerous patients with DED remain undiagnosed and inadequately treated, experiencing various subjective symptoms and a decrease in quality of life and work productivi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9fa754110ce657944fe77f83af2aeb98
https://doi.org/10.2196/preprints.45218
https://doi.org/10.2196/preprints.45218
Autor:
Masaki Fukui, Yoko Ogawa, Shin Mukai, Mizuka Kamoi, Teru Asato, Yutaka Kawakami, Kazuo Tsubota
Publikováno v:
Journal of Ophthalmology, Vol 2017 (2017)
Purpose. To investigate whether the SNARE protein vesicle-associated membrane protein 8 (VAMP8) was implicated in the development of chronic ocular graft-versus-host disease (GVHD). Methods. Firstly, the chronic GVHD (cGVHD) and Sjögren’s syndrome
Externí odkaz:
https://doaj.org/article/da330b7e757046d2b15ea54e6f56f854
Autor:
Masahiro Kubo, Masaki Fukui, Yuma Ito, Tatsuya Kitao, Hiroaki Shirahase, Eiichi Hinoi, Yukio Yoneda
Publikováno v:
Journal of Pharmacological Sciences, Vol 124, Iss 2, Pp 276-286 (2014)
The pharmacological profile of (S)-7-(2-{2-[(E)-2-cyclopentylvinyl]-5-methyloxazol-4-yl}-ethoxy)-2-[(2E,4E)-hexadienoyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (KY-201), a peroxisome proliferator-activated receptor (PPAR) γ agonist, was co
Externí odkaz:
https://doaj.org/article/69fd3e12134b4999aa10ddf4452b9e99
Autor:
Tatsuya Kitao, Megumi Yamamoto, Masaki Fukui, Yuma Ito, Shohei Furukawa, Hiroaki Shirahase, Ko Morishita
Publikováno v:
Biological and Pharmaceutical Bulletin. 44:659-668
Peroxisome proliferator-activated receptor γ (PPARγ) modulators are expected to exert anti-diabetic effects without PPARγ-related adverse effects, such as fluid retention, weight gain, and bone loss. The present study showed that the novel tetrazo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4dc1b2775acb368ef60aaccbc07952e
https://doi.org/10.1248/bpb.b20-01002
https://doi.org/10.1248/bpb.b20-01002